Guidelines for use of Biological Agents in Psoriasis: Commonalities and Differences

被引：0
作者：
Ozarmagan, Guzin [1 ]
Babuna, Goncaguel [1 ]
机构：
[1] Istanbul Univ, Istanbul Tip Fak, Dermatol Anabilim Dali, Istanbul, Turkey
来源：
TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY | 2008年 / 42卷
关键词：
Psoriasis; biological agents; guidelines;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Currently, biological agents are used worldwide particularly in the treatment of severe psoriasis. Nevertheless dermatologists still have limited clinical experience with these promising new treatments. Biological agents should only be used in a systematic and controlled manner since they are relatively expensive, with insufficient data about their long-term efficacy and toxicity. Therefore, several countries developed national guidelines for use of biological agents in psoriasis, considering the evidence-based literature data and personal views of clinical experts. Our review's purpose is to emphasize the commonalities and differences of these guidelines. (Turkderm 2008; 42 Suppl 2: 60-5)
引用
收藏
页码：60 / 65
页数：6
相关论文
共 23 条
  • [1] National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents
    Doherty, Sean D.
    Van Voorhees, Abby
    Lebwohl, Mark G.
    Korman, Neil J.
    Young, Melodie S.
    Hsu, Sylvia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (02) : 209 - 217
  • [2] The economic impact of psoriasis increases with psoriasis severity
    Feldman, SR
    Fleischer, AB
    Reboussin, DM
    Rapp, SR
    Bradham, DD
    Exum, ML
    Clark, AR
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (04) : 564 - 569
  • [3] Patient satisfaction with psoriasis therapies: An update and introduction to biologic therapy
    Finlay, AY
    Ortonne, JP
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2004, 8 (05) : 310 - 320
  • [4] Gottlieb AB, 2008, J DRUGS DERMATOL, V7, P563
  • [5] Psoriasis comorbidities
    Gottlieb, Alice B.
    Chao, Chun
    Dann, Frank
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2008, 19 (01) : 5 - 21
  • [6] Integrating biologic agents into management of moderate-to-severe psoriasis: A consensus of the Canadian Psoriasis Expert Panel
    Guenther, L
    Langley, RG
    Shear, NH
    Bissonnette, R
    Ho, V
    Lynde, C
    Murray, E
    Papp, K
    Poulin, Y
    Zip, C
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2004, 8 (05) : 321 - 337
  • [7] Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases
    Lam, Joseph
    Polifka, Janine E.
    Dohil, Magdalene A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (02) : 295 - 315
  • [8] Psoriasis
    Lebwohl, M
    [J]. LANCET, 2003, 361 (9364) : 1197 - 1204
  • [9] From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis
    Lebwohl, Mark
    Bagel, Jerry
    Gelfand, Joel M.
    Gladmam, Dafna
    Gordon, Kenneth B.
    Hsu, Sylvia
    Kalb, Robert E.
    Kimball, Alexa Boer
    Korman, Neil J.
    Krueger, Gerald G.
    Mease, Philip
    Morison, Warwick L.
    Paller, Amy
    Pariser, David M.
    Ritchlin, Christopher
    Strober, Bruce
    Van Voorhees, Abby
    Weinstein, Gerald D. R.
    Young, Melodie
    Horn, Liz
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (01) : 94 - 105
  • [10] Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
    Menter, Alan
    Gottlieb, Alice
    Feldman, Steven R.
    Van Voorhees, Abby S.
    Leonardi, Craig L.
    Gordon, Kenneth B.
    Lebwohl, Mark
    Koo, John Y. M.
    Elmets, Craig A.
    Korman, Neil J.
    Beutner, Karl R.
    Bhushan, Reva
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (05) : 826 - 850
123